以Boc-(4R)-羟基-(2S)-脯氨酸为原料,在NaH作用下与苄位溴代试剂发生醚化反应,合成了几种4-取代-L-脯氨酸类手性催化剂,即在(4R)-羟基-(2S)-脯氨酸的4-位上引入不同的苄氧基以期提高其催化活性和脂溶性,并通过1 H NMR、13 C NMR和HRMS...以Boc-(4R)-羟基-(2S)-脯氨酸为原料,在NaH作用下与苄位溴代试剂发生醚化反应,合成了几种4-取代-L-脯氨酸类手性催化剂,即在(4R)-羟基-(2S)-脯氨酸的4-位上引入不同的苄氧基以期提高其催化活性和脂溶性,并通过1 H NMR、13 C NMR和HRMS对合成产物的结构进行表征,确定其为目标产物.实验结果还表明,当苯环上连有强的吸电子基团时反应很难进行,而当连有给电子基团时反应相对较容易进行且反应条件较温和.展开更多
A series of tri-substituted chiral pyrrolidin-2-one derivatives have been designed and synthesized as CC chemokine receptor 4 （CCR4） antagonists. The structure of CCR4 was built by homology modeling. Asymmetric synt...A series of tri-substituted chiral pyrrolidin-2-one derivatives have been designed and synthesized as CC chemokine receptor 4 （CCR4） antagonists. The structure of CCR4 was built by homology modeling. Asymmetric synthesis was applied to synthesize the R,R configuration chiral pyrrolidin-2-one scaffold. The stereoisomeric con- figurations of the compounds were identified by 2D I H-~H COSY spectroscopy and 1D NOESY spectroscopy. This method was more economical and convenient than traditional X-ray single crystal diffraction. In addition, the inter- actions between these compounds and the N-terminal extracellular tail of CCR4 were studied using capillary zone electrophoresis. The CCR4 chemotaxis inhibition effect was tested in CCR4-transfected HEK293 cells. Several compounds showed potent activities as CCR4 antagonists. Among these compounds, lc is the most active one. Its apparent binding constant of CZE experiment result is （1.569±0.11）× 10s L·mol ^-1, and its percentage inhibition of the HEK293/CCR4 cells migration with the concentration of I gmol·L ^-1 in DMSO is 59%. And compound If has slightly higher affinity to N-terminal of CCR4 according to its apparent binding constant than lb because of the in- troduced ester linkage. Further studies on the mechanism of these compounds are in progress.展开更多
文摘以Boc-(4R)-羟基-(2S)-脯氨酸为原料,在NaH作用下与苄位溴代试剂发生醚化反应,合成了几种4-取代-L-脯氨酸类手性催化剂,即在(4R)-羟基-(2S)-脯氨酸的4-位上引入不同的苄氧基以期提高其催化活性和脂溶性,并通过1 H NMR、13 C NMR和HRMS对合成产物的结构进行表征,确定其为目标产物.实验结果还表明,当苯环上连有强的吸电子基团时反应很难进行,而当连有给电子基团时反应相对较容易进行且反应条件较温和.
基金This work was financially supported by the National Natural Science Foundation of China，the National Major Science & Technology Specific Project，Young Scientific Research Fund Project for Department of Science and Technology of Jilin Province
文摘A series of tri-substituted chiral pyrrolidin-2-one derivatives have been designed and synthesized as CC chemokine receptor 4 （CCR4） antagonists. The structure of CCR4 was built by homology modeling. Asymmetric synthesis was applied to synthesize the R,R configuration chiral pyrrolidin-2-one scaffold. The stereoisomeric con- figurations of the compounds were identified by 2D I H-~H COSY spectroscopy and 1D NOESY spectroscopy. This method was more economical and convenient than traditional X-ray single crystal diffraction. In addition, the inter- actions between these compounds and the N-terminal extracellular tail of CCR4 were studied using capillary zone electrophoresis. The CCR4 chemotaxis inhibition effect was tested in CCR4-transfected HEK293 cells. Several compounds showed potent activities as CCR4 antagonists. Among these compounds, lc is the most active one. Its apparent binding constant of CZE experiment result is （1.569±0.11）× 10s L·mol ^-1, and its percentage inhibition of the HEK293/CCR4 cells migration with the concentration of I gmol·L ^-1 in DMSO is 59%. And compound If has slightly higher affinity to N-terminal of CCR4 according to its apparent binding constant than lb because of the in- troduced ester linkage. Further studies on the mechanism of these compounds are in progress.
